Paul Erdman

749 citations

18 papers · 387 · h-index 10

Impact in

Organic Chemistry top 10%
- Synthesis and biological activity
- Click Chemistry and Applications
- Quinazolinone synthesis and applications
- Synthesis and Characterization of Heterocyclic Compounds
Toxicology

Papers in

Molecular Biology 8
- Protein Degradation and Inhibitors 4
Oncology 8
- Cytokine Signaling Pathways and Interactions 5
- Peptidase Inhibition and Analysis 3

Co-authors: Moorthy S. S. Palanki (7 shared papers)Lynn J. Ransone (6 shared papers)Mark J. Suto (5 shared papers)Mark E. Goldman (4 shared papers)Philip B. Cox (2 shared papers)Anthony M. Manning (3 shared papers)Robert W. Sullivan (3 shared papers)Brydon L. Bennett (2 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Medicinal Chemistry (2 papers)Journal of Clinical Oncology (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)ACS Medicinal Chemistry Letters (1 paper)
Partner nations: United States Switzerland Japan

In The Last Decade

Paul Erdman

18 papers receiving 361 citations

Peers

Countries citing papers authored by Paul Erdman

Since Specialization

Citations

This map shows the geographic impact of Paul Erdman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Erdman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Erdman more than expected).

Fields of papers citing papers by Paul Erdman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Erdman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Erdman. The network helps show where Paul Erdman may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Erdman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Erdman Line = papers co-authored together Paul Erdman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Discovery of Antibacterial Biotin Carboxylase Inhibitors by Virtual Screening and Fragment-Based Approaches ACS Chemical Biology ·Igor Mochalkin, J. Richard Miller, Lakshmi Narasimhan, V. Thanabal, Paul Erdman, Philip B. Cox, J. V. N. Vara Prasad, Sandra Lightle, Michael D. Huband, C. Kendall Stover	2009	75
2	Inhibitors of NF-κB and AP-1 Gene Expression: SAR Studies on the Pyrimidine Portion of 2-Chloro-4-trifluoromethylpyrimidine-5-[N-(3‘,5‘-bis(trifluoromethyl)phenyl)carboxamide] Journal of Medicinal Chemistry ·Moorthy S. S. Palanki, Paul Erdman, Leah M. Gayo‐Fung, Graziella Shevlin, Robert W. Sullivan, Mark E. Goldman, Lynn J. Ransone, Brydon L. Bennett, Anthony M. Manning, Mark J. Suto	2000	73
3	Structure–Activity Relationship Studies of Ethyl 2-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino]-4-(trifluoromethyl)pyrimidine-5-carboxylate: An Inhibitor of AP-1 and NF-κB Mediated Gene Expression Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki, Leah M. Gayo‐Fung, Graziella Shevlin, Paul Erdman, Mark Sato, Mark E. Goldman, Lynn J. Ransone, Cheryl Spooner	2002	36
4	2-Chloro-4-(trifluoromethyl)pyrimidine-5-N-(3‘,5‘-bis(trifluoromethyl)phenyl)- carboxamide: A Potent Inhibitor of NF-κB- and AP-1-Mediated Gene Expression Identified Using Solution-Phase Combinatorial Chemistry Journal of Medicinal Chemistry ·Robert W. Sullivan, Colin G. Bigam, Paul Erdman, Moorthy S. S. Palanki, David W. Anderson, Mark E. Goldman, Lynn J. Ransone, Mark J. Suto	1998	36
5	The design and synthesis of novel orally active inhibitors of AP-1 and NF-κB mediated transcriptional activation. SAR of In vitro and In vivo studies Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki, Paul Erdman, Minghuan Ren, Mark J. Suto, Brydon L. Bennett, Anthony M. Manning, Lynn J. Ransone, Cheryl Spooner, Sonal J. Desai, Arnie Ow, Ryuichi Totsuka, Peter Tsao, Wataru Toriumi	2003	32
6	Design and Synthesis of Pyrrolidine-based Fragments That Sample Three-dimensional Molecular Space ACS Medicinal Chemistry Letters ·Philip Garner, Philip B. Cox, Upendra A. Rathnayake, Nicholas Holloran, Paul Erdman	2019	30
7	Novel inhibitors of AP-1 and NF-κB mediated gene expression: structure–activity relationship studies of ethyl 4-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoromethyl)pyrimidine-5-carboxylate Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki, Paul Erdman, Anthony M. Manning, Arnold Ow, Lynn J. Ransone, Cheryl Spooner, Carla M. Suto, Mark J. Suto	2000	29
8	Inhibition of Nuclear Factor-κB in T Cells Suppresses Lung Fibrosis American Journal of Respiratory and Critical Care Medicine ·Hajime Fujimoto, Corina N. D’Alessandro‐Gabazza, Moorthy S. S. Palanki, Paul Erdman, Takehiro Takagi, Esteban C. Gabazza, Nelson E. Bruno, Yutaka Yano, Tatsuya Hayashi, Shigenori Tamaki, Yasuhiro Sumida, Yukihiko Adachi, Koji Suzuki, Osamu Taguchi	2007	22
9	BTX-1188, a first-in-class dual degrader of GSPT1 and IKZF1/3, for treatment of acute myeloid leukemia (AML) and solid tumors. Journal of Clinical Oncology ·Aparajita H. Chourasia, Hannah Majeski, Angela Pasis, Paul Erdman, Ashwini Oke, David Hecht, David Lonergan, Frank Mercurio, Kyle Chan, Dung Thai, Leah Fung	2022	13
10	The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance Journal of Molecular Medicine ·Jianxuan Zou, Richard J. Jones, Hua Wang, Isere Kuiatse, Fazal Shirazi, Elisabet E. Manasanch, Hans C. Lee, Robert Sullivan, Leah Fung, Normand Richard, Paul Erdman, Eduardo Torres, David Hecht, Imelda Lam, Brooke McElwee, Aparajita H. Chourasia, Kyle Chan, Frank Mercurio, David Stirling, Robert Z. Orlowski	2020	9
11	Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors – Lead optimization – Part III Bioorganic & Medicinal Chemistry Letters ·Claude Barberis, James Pribish, Elina Tserlin, Alexandre Gross, Mark Czekaj, Matthieu Barragué, Paul Erdman, Sachin Maniar, John Jiang, Luke Fire, Vinod F. Patel, Andrew Hebert, Mikhail Levit, Anlai Wang, Frank F. Sun, Shih-Min A. Huang	2018	8
12	Discovery of SARxxxx92, a pan-PIM kinase inhibitor, efficacious in a KG1 tumor model Bioorganic & Medicinal Chemistry Letters ·Claude Barberis, Paul Erdman, Mark Czekaj, Luke Fire, James Pribish, Elina Tserlin, Sachin Maniar, Joseph D. Batchelor, Jinyu Liu, Vinod F. Patel, Andrew Hebert, Mikhail Levit, Anlai Wang, Frank F. Sun, Shih-Min A. Huang	2020	7
13	Bioavailable Dual-Protein Degraders of CK1α and Transcriptional Kinase CDK9 As Potential Therapeutics for Hematological Malignancies Blood ·Leah Fung, Aparajita H. Chourasia, Eduardo Torres, Imelda Lam, Paul Erdman, David Hecht, Robert Sullivan, Brooke McElwee, Normand Richard, Avanthika Venkatachalam, Irit Snir-Alkalay, Kyle Chan, Frank Mercurio, Yinon Ben‐Neriah, David Stirling	2019	5
14	Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors – Lead series identification – Part II Bioorganic & Medicinal Chemistry Letters ·Claude Barberis, Neil Moorcroft, James Pribish, Elina Tserlin, Alexandre Gross, Mark Czekaj, Matthieu Barragué, Paul Erdman, Tahir Majid, Joseph D. Batchelor, Mikhail Levit, Andrew Hebert, Liduo Shen, Sandra Moreno-Mazza, Anlai Wang	2017	5
15	Outdoor Vector Lab The Physics Teacher ·Paul Erdman	2004	2
16	Abstract 1963: Targeting hematological malignancies with two functionally and mechanistically distinct classes of cereblon mediated protein homeostatic modulators Cancer Research ·Aparajita H. Chourasia, Leah Fung, Angela Pasis, Brooke McElwee, Angela Schoolmeesters, Normand Richard, Imelda Lam, Eduardo Torres, Paul Erdman, Robert Sullivan, David Hecht, Kyle Chan, Frank Mercurio, David Stirling	2020	2
17	ChemInform Abstract: 2‐Chloro‐4‐(trifluoromethyl)pyrimidine‐5‐N‐(3′,5′‐bis (trifluoromethyl)phenyl)carboxamide: A Potent Inhibitor of NF‐ϰB‐ and AP‐1‐Mediated Gene Expression Identified Using Solution‐Phase Combinatorial Chemistry. ChemInform ·Robert W. Sullivan, Colin G. Bigam, Paul Erdman, Moorthy S. S. Palanki, David W. Anderson, Mark E. Goldman, Lynn J. Ransone, Mark J. Suto	1998	2
18	Discovery of a PDE4B and PDE4D selective bifunctional degrader for management of chronic inflammatory disorders Journal of Translational Autoimmunity ·Arvind Shakya, Qiao Liu, Chon Lai, Sherry Baker, Steven Greene, Paul Erdman, Athri D. Rathnayake, Angela Schoolmeesters, Connor M. Blair, Elka Kyurkchieva, Navin Rajapakse, Imelda Lam, Yuan Yan Sin, George S. Baillie, Shenlin Huang, Aparajita H. Chourasia, Leah Fung	2025	1

About Paul Erdman

Paul Erdman is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Hematology and Cancer Research, having authored 18 papers that have together received 387 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), NF-κB Signaling Pathways (4 papers), Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (4 papers), Cancer Mechanisms and Therapy (3 papers), Quinazolinone synthesis and applications (3 papers), Peptidase Inhibition and Analysis (3 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Organic Chemistry (186 citations), Toxicology (15 citations), Cancer Research (59 citations), Pharmaceutical Science (21 citations) and Molecular Biology (183 citations). Paul Erdman has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Moorthy S. S. Palanki, Lynn J. Ransone, Mark J. Suto, Mark E. Goldman, Philip B. Cox, Anthony M. Manning, Robert W. Sullivan, Brydon L. Bennett, V. Thanabal and J. V. N. Vara Prasad. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and ACS Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Paul Erdman

Impact in

Papers in i

In The Last Decade

Paul Erdman

Peers

Countries citing papers authored by Paul Erdman

Fields of papers citing papers by Paul Erdman

All Works

About Paul Erdman

Explore authors with similar magnitude of impact

Papers in